Literature DB >> 25115783

Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.

Thomas Bontant1, Sophie Le Garrec1, David Avran1, Stephane Dauger1.   

Abstract

A 5-year-old boy from the Congo, was admitted for hyperleucocytic acute lymphoblastic leukaemia, with a high risk of tumour lysis syndrome (TLS). He had splenomegaly and mediastinal lymphadenopathy on chest X-ray. We started steroids and hyperhydration with rasburicase to prevent TLS. Respiratory failure with mediastinal enlargement developed rapidly. A few hours after intensive care unit (ICU) admission, he was started on mechanical ventilation. Chemotherapy was started immediately given the strong suspicion of mediastinal compression. Low oxygen saturation with high partial arterial oxygen pressure persisted. Blood tests confirmed 20% methaemoglobinaemia and glucose-6-phosphate dehydrogenase (G6PD) deficiency. Allopurinol was substituted for rasburicase. The methaemoglobinaemia disappeared rapidly and he was discharged from the ICU after 72 h. In case of rasburicase use, a close clinical monitoring is mandatory, especially in populations where G6PD deficiency is highly prevalent. Methaemoglobinaemia must be suspected in case of low oxygen saturation when all other potential causes have been ruled out. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25115783      PMCID: PMC4139556          DOI: 10.1136/bcr-2014-204706

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  Rasburicase (Elitek): a novel agent for tumor lysis syndrome.

Authors:  Sis Ueng
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-07

2.  Report of two cases of rasburicase-induced methemoglobinemia.

Authors:  Nora Kizer; Emily Martinez; Matthew Powell
Journal:  Leuk Lymphoma       Date:  2006-12

3.  Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia.

Authors:  Scott C Borinstein; Min Xu; Douglas S Hawkins
Journal:  Pediatr Blood Cancer       Date:  2008-01       Impact factor: 3.167

4.  Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.

Authors:  Mohamad Bassam Sonbol; Hemang Yadav; Rakhee Vaidya; Vishal Rana; Thomas E Witzig
Journal:  Am J Hematol       Date:  2012-05-10       Impact factor: 10.047

5.  Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient.

Authors:  Priya Bhat; India Sisler; Anderson B Collier
Journal:  Pediatr Blood Cancer       Date:  2008-10       Impact factor: 3.167

6.  Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.

Authors:  C H Pui; H H Mahmoud; J M Wiley; G M Woods; G Leverger; B Camitta; C Hastings; S M Blaney; M V Relling; G H Reaman
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

7.  Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.

Authors:  P J Rosen; C Johnson; W G McGehee; E Beutler
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

8.  Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.

Authors:  T Bauters; V Mondelaers; H Robays; H De Wilde; Y Benoit; B De Moerloose
Journal:  Int J Clin Pharm       Date:  2011-02-04

Review 9.  Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.

Authors:  Maria A Lopez-Olivo; Gregory Pratt; Shana L Palla; Abdulla Salahudeen
Journal:  Am J Kidney Dis       Date:  2013-05-14       Impact factor: 8.860

10.  Congenital methemoglobinemia: a rare cause of cyanosis in the newborn--a case report.

Authors:  Shonola S Da-Silva; Imran S Sajan; Joseph P Underwood
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

View more
  2 in total

Review 1.  Germline genetic variants with implications for disease risk and therapeutic outcomes.

Authors:  Amy L Pasternak; Kristen M Ward; Jasmine A Luzum; Vicki L Ellingrod; Daniel L Hertz
Journal:  Physiol Genomics       Date:  2017-09-08       Impact factor: 3.107

2.  Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.

Authors:  Garrett B Sherwood; Rita D Paschal; Jill Adamski
Journal:  Clin Case Rep       Date:  2016-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.